SlideShare a Scribd company logo
www.orpha.net
HIPBI-RD
Harmonising phenomics information for a better
interoperability in the RD field
Ana Rath, Annie Olry, Marc Hanauer, Peter Robinson, Sebastian Köhler,
Michael Brudno, Helen Parkinson, Simon Jupp,Tudor Groza
ana.rath@inserm.fr
Human Variome Project 6th Bienal meeting – UNESCO, Paris
June 2016
HIPBI-RD
• Aims:
– Contribute to harmonisation of phenotype annotations
– Contribute to interoperability between patient-centered
resources and genetic-centered resources
We aim to provide the community with an integrated, RD-specific informatics
ecosystem that will harmonize the way phenomics information is stored in databases
and in patient files worldwide, and thereby contribute to interoperability. This
ecosystem will consist of a suite of tools and ontologies, optimized to work
together, and available to clinicians and scientists through commonly used software
repositories. Additionally, the ecosystem will contribute to the interpretation of
variants identified through exome and full genome sequencing by harmonizing the
way phenotypic information is collected, thus improving diagnostics.
Specific objectives
• Integrate Human Phenotype Ontology (HPO) and
Orphanet Rare Disease Ontology (ORDO).
• Have ORDO & HPO translated in 7 languages.
• Enrich rare disorder annotations via automated
concept recognition (literature, records).
• Enrich rare disorder annotations via
Crowdsourcing.
• Improve algorithms to allow clinical and genetic
differential diagnosis.
– Improve Phenomizer and Genomizer
Orphanet scientific content
UniProt
Reactome
OMIM
ICD10
ICD11
UMLS
MedDRA
SNOMED
CT
gene
OMIM
HGNC
IUPHAR
ensembl
Genatlas
ORPHA
ICF-CY
derived
terms
A. Rath, A. Olry, M. Hanauer, Inserm, US14, Paris France
Orphanet Rare Diseases Onntology (ORDO)
Orphanet & European Bioinformatics Institute (EBI)
Helen Parkinson, Simon Jupp, EMBL-EBI, Hinxton, UK
Peter Robinson, Sebastian Köhler, La Charité, Berlin, Germany
HPO controlled vocabulary and the Phenomizer
https://compbio.charite.de/phenomizer/
HPO annotations of Orphanet Rare Disorders
Around 6,000 rare disorders HPO phenotypes
Frequencies Diagnostic criteria
Obligate (100%) Pathognomonic sign
Very frequent (99-80%) Diagnostic criterion
Frequent (79-30%)
Occasional (29–5%)
Very rare (1-4%)
Absent 0%
Annotated by
Orphanet
Disseminated
by Orphanet
and HPO
2,340 rare disorders 5,750 phenotypes
49,600 annotations
ORDO HPO
Orphanet HPO
Ontologies integrated
Bio-named entity
recognition
Phenome
Central
Phenomizer
Exomizer
Hipbi-RD ecosystem
Literature
Re-use
PhenoTips
Crowdsourcing
OKM
Projet HIPBI-RD
Bio-named recognition
Bio-LarK CR
Tudor Groza , Garvan Institute, Australia
https://phenotips.org/
Michael Brudno, SickKids Hospital, Toronto, Canada
In conclusion…
• Having structured data in databases (but also in the
healthcare setting) is a cornerstone to foster research by
allowing for agregation of interoperable data.
• Providing an integrated, computable ontologies ecosystem
will help to standardisation and harmonisation of phenotypic
and clinical annotations.
• The ecosystem will contribute to the interpretation of variants
identified through exome and full genome sequencing by
harmonizing the way phenotypic information is collected, thus
improving diagnostics.
THANK YOU FOR YOUR ATTENTION!

More Related Content

Similar to HIPBI-RD: Harmonising phenomics information for a better interoperability in the rare disease field - Ana Rath

Haendel clingenetics.3.14.14
Haendel clingenetics.3.14.14Haendel clingenetics.3.14.14
Haendel clingenetics.3.14.14mhaendel
 
Deep phenotyping for everyone
Deep phenotyping for everyoneDeep phenotyping for everyone
Deep phenotyping for everyone
mhaendel
 
Hodgetts et al., 2016 (gen-2016-0010)
Hodgetts et al., 2016 (gen-2016-0010)Hodgetts et al., 2016 (gen-2016-0010)
Hodgetts et al., 2016 (gen-2016-0010)Joe Ostoja-Starzewski
 
Computing on Phenotypes AMP 2015
Computing on Phenotypes AMP 2015Computing on Phenotypes AMP 2015
Computing on Phenotypes AMP 2015
Chris Mungall
 
Ayo Akinrinmade - Cambridge Rare Disease Summit 2015
Ayo Akinrinmade - Cambridge Rare Disease Summit 2015Ayo Akinrinmade - Cambridge Rare Disease Summit 2015
Ayo Akinrinmade - Cambridge Rare Disease Summit 2015
CamRARE Disease Network
 
Bioinformatics and NGS for advancing in hearing loss research
Bioinformatics and NGS for advancing in hearing loss researchBioinformatics and NGS for advancing in hearing loss research
Bioinformatics and NGS for advancing in hearing loss research
Joaquin Dopazo
 
HEVnet: Sharing sequences & metadata of hepatitis E virus
HEVnet: Sharing sequences & metadata of hepatitis E virus HEVnet: Sharing sequences & metadata of hepatitis E virus
HEVnet: Sharing sequences & metadata of hepatitis E virus
AgnethaRIVM1
 
Context is Everything: Integrating Genomics, Epidemiological and Clinical Dat...
Context is Everything: Integrating Genomics, Epidemiological and Clinical Dat...Context is Everything: Integrating Genomics, Epidemiological and Clinical Dat...
Context is Everything: Integrating Genomics, Epidemiological and Clinical Dat...
Emma Griffiths
 
Monarch Initiative Poster - Rare Disease Symposium 2015
Monarch Initiative Poster - Rare Disease Symposium 2015Monarch Initiative Poster - Rare Disease Symposium 2015
Monarch Initiative Poster - Rare Disease Symposium 2015
Nicole Vasilevsky
 
Integrative and translational analysis of the phenome
Integrative and translational analysis of the phenomeIntegrative and translational analysis of the phenome
Integrative and translational analysis of the phenomeRobert Hoehndorf
 
IRIDA's Genomic epidemiology application ontology (GenEpiO): Genomic, clinica...
IRIDA's Genomic epidemiology application ontology (GenEpiO): Genomic, clinica...IRIDA's Genomic epidemiology application ontology (GenEpiO): Genomic, clinica...
IRIDA's Genomic epidemiology application ontology (GenEpiO): Genomic, clinica...
Emma Griffiths
 
Gen epio immem_griffiths
Gen epio immem_griffithsGen epio immem_griffiths
Gen epio immem_griffiths
IRIDA_community
 
FAO partnerships on health risk and control of influenza and emerging zoonoses
FAO partnerships on health risk and control of influenza and emerging zoonosesFAO partnerships on health risk and control of influenza and emerging zoonoses
FAO partnerships on health risk and control of influenza and emerging zoonosesTariq Mustafa Mohamed Ali
 
Approaches to the definition of common data elements
Approaches to the definition of common data elementsApproaches to the definition of common data elements
Approaches to the definition of common data elements
bndmr
 
GIGA2 Structuring Phenotype Data
GIGA2 Structuring Phenotype DataGIGA2 Structuring Phenotype Data
GIGA2 Structuring Phenotype Data
Chris Mungall
 
Pestforecast: Surveillance and early warning systems for climate sensitive di...
Pestforecast: Surveillance and early warning systems for climate sensitive di...Pestforecast: Surveillance and early warning systems for climate sensitive di...
Pestforecast: Surveillance and early warning systems for climate sensitive di...
ILRI
 
Whole Genome Sequencing (WGS) for food safety management in France: Example...
Whole Genome Sequencing (WGS)  for food safety management in France:  Example...Whole Genome Sequencing (WGS)  for food safety management in France:  Example...
Whole Genome Sequencing (WGS) for food safety management in France: Example...
ExternalEvents
 
10-3. Rare disease registries. Samantha Parker (eng)
10-3. Rare disease registries. Samantha Parker (eng)10-3. Rare disease registries. Samantha Parker (eng)
10-3. Rare disease registries. Samantha Parker (eng)KidneyOrgRu
 
Grafström - Lush Prize Conference 2014
Grafström - Lush Prize Conference 2014Grafström - Lush Prize Conference 2014
Grafström - Lush Prize Conference 2014
LushPrize
 
Standards for public health genomic epidemiology - Biocuration 2015
Standards for public health genomic epidemiology - Biocuration 2015Standards for public health genomic epidemiology - Biocuration 2015
Standards for public health genomic epidemiology - Biocuration 2015
Melanie Courtot
 

Similar to HIPBI-RD: Harmonising phenomics information for a better interoperability in the rare disease field - Ana Rath (20)

Haendel clingenetics.3.14.14
Haendel clingenetics.3.14.14Haendel clingenetics.3.14.14
Haendel clingenetics.3.14.14
 
Deep phenotyping for everyone
Deep phenotyping for everyoneDeep phenotyping for everyone
Deep phenotyping for everyone
 
Hodgetts et al., 2016 (gen-2016-0010)
Hodgetts et al., 2016 (gen-2016-0010)Hodgetts et al., 2016 (gen-2016-0010)
Hodgetts et al., 2016 (gen-2016-0010)
 
Computing on Phenotypes AMP 2015
Computing on Phenotypes AMP 2015Computing on Phenotypes AMP 2015
Computing on Phenotypes AMP 2015
 
Ayo Akinrinmade - Cambridge Rare Disease Summit 2015
Ayo Akinrinmade - Cambridge Rare Disease Summit 2015Ayo Akinrinmade - Cambridge Rare Disease Summit 2015
Ayo Akinrinmade - Cambridge Rare Disease Summit 2015
 
Bioinformatics and NGS for advancing in hearing loss research
Bioinformatics and NGS for advancing in hearing loss researchBioinformatics and NGS for advancing in hearing loss research
Bioinformatics and NGS for advancing in hearing loss research
 
HEVnet: Sharing sequences & metadata of hepatitis E virus
HEVnet: Sharing sequences & metadata of hepatitis E virus HEVnet: Sharing sequences & metadata of hepatitis E virus
HEVnet: Sharing sequences & metadata of hepatitis E virus
 
Context is Everything: Integrating Genomics, Epidemiological and Clinical Dat...
Context is Everything: Integrating Genomics, Epidemiological and Clinical Dat...Context is Everything: Integrating Genomics, Epidemiological and Clinical Dat...
Context is Everything: Integrating Genomics, Epidemiological and Clinical Dat...
 
Monarch Initiative Poster - Rare Disease Symposium 2015
Monarch Initiative Poster - Rare Disease Symposium 2015Monarch Initiative Poster - Rare Disease Symposium 2015
Monarch Initiative Poster - Rare Disease Symposium 2015
 
Integrative and translational analysis of the phenome
Integrative and translational analysis of the phenomeIntegrative and translational analysis of the phenome
Integrative and translational analysis of the phenome
 
IRIDA's Genomic epidemiology application ontology (GenEpiO): Genomic, clinica...
IRIDA's Genomic epidemiology application ontology (GenEpiO): Genomic, clinica...IRIDA's Genomic epidemiology application ontology (GenEpiO): Genomic, clinica...
IRIDA's Genomic epidemiology application ontology (GenEpiO): Genomic, clinica...
 
Gen epio immem_griffiths
Gen epio immem_griffithsGen epio immem_griffiths
Gen epio immem_griffiths
 
FAO partnerships on health risk and control of influenza and emerging zoonoses
FAO partnerships on health risk and control of influenza and emerging zoonosesFAO partnerships on health risk and control of influenza and emerging zoonoses
FAO partnerships on health risk and control of influenza and emerging zoonoses
 
Approaches to the definition of common data elements
Approaches to the definition of common data elementsApproaches to the definition of common data elements
Approaches to the definition of common data elements
 
GIGA2 Structuring Phenotype Data
GIGA2 Structuring Phenotype DataGIGA2 Structuring Phenotype Data
GIGA2 Structuring Phenotype Data
 
Pestforecast: Surveillance and early warning systems for climate sensitive di...
Pestforecast: Surveillance and early warning systems for climate sensitive di...Pestforecast: Surveillance and early warning systems for climate sensitive di...
Pestforecast: Surveillance and early warning systems for climate sensitive di...
 
Whole Genome Sequencing (WGS) for food safety management in France: Example...
Whole Genome Sequencing (WGS)  for food safety management in France:  Example...Whole Genome Sequencing (WGS)  for food safety management in France:  Example...
Whole Genome Sequencing (WGS) for food safety management in France: Example...
 
10-3. Rare disease registries. Samantha Parker (eng)
10-3. Rare disease registries. Samantha Parker (eng)10-3. Rare disease registries. Samantha Parker (eng)
10-3. Rare disease registries. Samantha Parker (eng)
 
Grafström - Lush Prize Conference 2014
Grafström - Lush Prize Conference 2014Grafström - Lush Prize Conference 2014
Grafström - Lush Prize Conference 2014
 
Standards for public health genomic epidemiology - Biocuration 2015
Standards for public health genomic epidemiology - Biocuration 2015Standards for public health genomic epidemiology - Biocuration 2015
Standards for public health genomic epidemiology - Biocuration 2015
 

More from Human Variome Project

ClinVar: Aggregating Data to Improve Variant Interpretation - Melissa Landrum
ClinVar: Aggregating Data to Improve Variant Interpretation - Melissa LandrumClinVar: Aggregating Data to Improve Variant Interpretation - Melissa Landrum
ClinVar: Aggregating Data to Improve Variant Interpretation - Melissa Landrum
Human Variome Project
 
The BRCA Share(TM) Consortium - Christophe Beroud
The BRCA Share(TM) Consortium - Christophe BeroudThe BRCA Share(TM) Consortium - Christophe Beroud
The BRCA Share(TM) Consortium - Christophe Beroud
Human Variome Project
 
Establishing validity, reproducibility, and utility of highly scalable geneti...
Establishing validity, reproducibility, and utility of highly scalable geneti...Establishing validity, reproducibility, and utility of highly scalable geneti...
Establishing validity, reproducibility, and utility of highly scalable geneti...
Human Variome Project
 
The PhenX Toolkit: Standard Measures for Collaborative Research - Wayne Huggins
The PhenX Toolkit: Standard Measures for  Collaborative Research - Wayne HugginsThe PhenX Toolkit: Standard Measures for  Collaborative Research - Wayne Huggins
The PhenX Toolkit: Standard Measures for Collaborative Research - Wayne Huggins
Human Variome Project
 
Legal and regulatory challenges to data sharing for clinical genetics and ge...
Legal and regulatory challenges to  data sharing for clinical genetics and ge...Legal and regulatory challenges to  data sharing for clinical genetics and ge...
Legal and regulatory challenges to data sharing for clinical genetics and ge...
Human Variome Project
 
Report from the International Confederation of Countries Advisory Council - M...
Report from the International Confederation of Countries Advisory Council - M...Report from the International Confederation of Countries Advisory Council - M...
Report from the International Confederation of Countries Advisory Council - M...
Human Variome Project
 
Human variome project quality assessment criteria for variation databases - M...
Human variome project quality assessment criteria for variation databases - M...Human variome project quality assessment criteria for variation databases - M...
Human variome project quality assessment criteria for variation databases - M...
Human Variome Project
 
HVP Country Node: Venezuela - Aida Falcon de Vargas
HVP Country Node: Venezuela - Aida Falcon de VargasHVP Country Node: Venezuela - Aida Falcon de Vargas
HVP Country Node: Venezuela - Aida Falcon de Vargas
Human Variome Project
 
Human Genetics of Infectious Diseases - Laurent Abel
Human Genetics of Infectious Diseases - Laurent AbelHuman Genetics of Infectious Diseases - Laurent Abel
Human Genetics of Infectious Diseases - Laurent Abel
Human Variome Project
 
HVP Country Node: Malaysia - Zilfalil bin Alwi
HVP Country Node: Malaysia - Zilfalil bin AlwiHVP Country Node: Malaysia - Zilfalil bin Alwi
HVP Country Node: Malaysia - Zilfalil bin Alwi
Human Variome Project
 
GENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès Rötig
GENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès RötigGENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès Rötig
GENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès Rötig
Human Variome Project
 
The BRCA Challenge & Exchange: Progress and Plans - Gunnar Rätsch
The BRCA Challenge & Exchange: Progress and Plans - Gunnar RätschThe BRCA Challenge & Exchange: Progress and Plans - Gunnar Rätsch
The BRCA Challenge & Exchange: Progress and Plans - Gunnar Rätsch
Human Variome Project
 
Richard GH Cotton: He may have been a bit before his time - Michael Watson
Richard GH Cotton: He may have been a bit before his time - Michael WatsonRichard GH Cotton: He may have been a bit before his time - Michael Watson
Richard GH Cotton: He may have been a bit before his time - Michael Watson
Human Variome Project
 
Professor Richard Cotton - Finlay Macrae
Professor Richard Cotton - Finlay MacraeProfessor Richard Cotton - Finlay Macrae
Professor Richard Cotton - Finlay Macrae
Human Variome Project
 
HVP Country Node: Canada - Matthew Lebo
HVP Country Node: Canada - Matthew LeboHVP Country Node: Canada - Matthew Lebo
HVP Country Node: Canada - Matthew Lebo
Human Variome Project
 
Use of open, curated variant databases: ethics? Liability? - Bartha Knoppers
Use of open, curated variant databases: ethics? Liability? - Bartha KnoppersUse of open, curated variant databases: ethics? Liability? - Bartha Knoppers
Use of open, curated variant databases: ethics? Liability? - Bartha Knoppers
Human Variome Project
 
HVP6: Final Thoughts - John Burn & Raj Ramesar
HVP6: Final Thoughts - John Burn & Raj RamesarHVP6: Final Thoughts - John Burn & Raj Ramesar
HVP6: Final Thoughts - John Burn & Raj Ramesar
Human Variome Project
 
Report from the International Scientific Advisory Committee - John Burn
Report from the International Scientific Advisory Committee - John BurnReport from the International Scientific Advisory Committee - John Burn
Report from the International Scientific Advisory Committee - John Burn
Human Variome Project
 
HVP Country Node: Italy - Domenico Coviello
HVP Country Node: Italy - Domenico CovielloHVP Country Node: Italy - Domenico Coviello
HVP Country Node: Italy - Domenico Coviello
Human Variome Project
 
Rare and common variants contribute to the complex inheritance of Hirschsprun...
Rare and common variants contribute to the complex inheritance of Hirschsprun...Rare and common variants contribute to the complex inheritance of Hirschsprun...
Rare and common variants contribute to the complex inheritance of Hirschsprun...
Human Variome Project
 

More from Human Variome Project (20)

ClinVar: Aggregating Data to Improve Variant Interpretation - Melissa Landrum
ClinVar: Aggregating Data to Improve Variant Interpretation - Melissa LandrumClinVar: Aggregating Data to Improve Variant Interpretation - Melissa Landrum
ClinVar: Aggregating Data to Improve Variant Interpretation - Melissa Landrum
 
The BRCA Share(TM) Consortium - Christophe Beroud
The BRCA Share(TM) Consortium - Christophe BeroudThe BRCA Share(TM) Consortium - Christophe Beroud
The BRCA Share(TM) Consortium - Christophe Beroud
 
Establishing validity, reproducibility, and utility of highly scalable geneti...
Establishing validity, reproducibility, and utility of highly scalable geneti...Establishing validity, reproducibility, and utility of highly scalable geneti...
Establishing validity, reproducibility, and utility of highly scalable geneti...
 
The PhenX Toolkit: Standard Measures for Collaborative Research - Wayne Huggins
The PhenX Toolkit: Standard Measures for  Collaborative Research - Wayne HugginsThe PhenX Toolkit: Standard Measures for  Collaborative Research - Wayne Huggins
The PhenX Toolkit: Standard Measures for Collaborative Research - Wayne Huggins
 
Legal and regulatory challenges to data sharing for clinical genetics and ge...
Legal and regulatory challenges to  data sharing for clinical genetics and ge...Legal and regulatory challenges to  data sharing for clinical genetics and ge...
Legal and regulatory challenges to data sharing for clinical genetics and ge...
 
Report from the International Confederation of Countries Advisory Council - M...
Report from the International Confederation of Countries Advisory Council - M...Report from the International Confederation of Countries Advisory Council - M...
Report from the International Confederation of Countries Advisory Council - M...
 
Human variome project quality assessment criteria for variation databases - M...
Human variome project quality assessment criteria for variation databases - M...Human variome project quality assessment criteria for variation databases - M...
Human variome project quality assessment criteria for variation databases - M...
 
HVP Country Node: Venezuela - Aida Falcon de Vargas
HVP Country Node: Venezuela - Aida Falcon de VargasHVP Country Node: Venezuela - Aida Falcon de Vargas
HVP Country Node: Venezuela - Aida Falcon de Vargas
 
Human Genetics of Infectious Diseases - Laurent Abel
Human Genetics of Infectious Diseases - Laurent AbelHuman Genetics of Infectious Diseases - Laurent Abel
Human Genetics of Infectious Diseases - Laurent Abel
 
HVP Country Node: Malaysia - Zilfalil bin Alwi
HVP Country Node: Malaysia - Zilfalil bin AlwiHVP Country Node: Malaysia - Zilfalil bin Alwi
HVP Country Node: Malaysia - Zilfalil bin Alwi
 
GENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès Rötig
GENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès RötigGENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès Rötig
GENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès Rötig
 
The BRCA Challenge & Exchange: Progress and Plans - Gunnar Rätsch
The BRCA Challenge & Exchange: Progress and Plans - Gunnar RätschThe BRCA Challenge & Exchange: Progress and Plans - Gunnar Rätsch
The BRCA Challenge & Exchange: Progress and Plans - Gunnar Rätsch
 
Richard GH Cotton: He may have been a bit before his time - Michael Watson
Richard GH Cotton: He may have been a bit before his time - Michael WatsonRichard GH Cotton: He may have been a bit before his time - Michael Watson
Richard GH Cotton: He may have been a bit before his time - Michael Watson
 
Professor Richard Cotton - Finlay Macrae
Professor Richard Cotton - Finlay MacraeProfessor Richard Cotton - Finlay Macrae
Professor Richard Cotton - Finlay Macrae
 
HVP Country Node: Canada - Matthew Lebo
HVP Country Node: Canada - Matthew LeboHVP Country Node: Canada - Matthew Lebo
HVP Country Node: Canada - Matthew Lebo
 
Use of open, curated variant databases: ethics? Liability? - Bartha Knoppers
Use of open, curated variant databases: ethics? Liability? - Bartha KnoppersUse of open, curated variant databases: ethics? Liability? - Bartha Knoppers
Use of open, curated variant databases: ethics? Liability? - Bartha Knoppers
 
HVP6: Final Thoughts - John Burn & Raj Ramesar
HVP6: Final Thoughts - John Burn & Raj RamesarHVP6: Final Thoughts - John Burn & Raj Ramesar
HVP6: Final Thoughts - John Burn & Raj Ramesar
 
Report from the International Scientific Advisory Committee - John Burn
Report from the International Scientific Advisory Committee - John BurnReport from the International Scientific Advisory Committee - John Burn
Report from the International Scientific Advisory Committee - John Burn
 
HVP Country Node: Italy - Domenico Coviello
HVP Country Node: Italy - Domenico CovielloHVP Country Node: Italy - Domenico Coviello
HVP Country Node: Italy - Domenico Coviello
 
Rare and common variants contribute to the complex inheritance of Hirschsprun...
Rare and common variants contribute to the complex inheritance of Hirschsprun...Rare and common variants contribute to the complex inheritance of Hirschsprun...
Rare and common variants contribute to the complex inheritance of Hirschsprun...
 

Recently uploaded

Leaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdfLeaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdf
RenuJangid3
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
SAMIR PANDA
 
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
University of Maribor
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Sérgio Sacani
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
moosaasad1975
 
bordetella pertussis.................................ppt
bordetella pertussis.................................pptbordetella pertussis.................................ppt
bordetella pertussis.................................ppt
kejapriya1
 
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
David Osipyan
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Erdal Coalmaker
 
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
University of Maribor
 
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxThe use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
MAGOTI ERNEST
 
Toxic effects of heavy metals : Lead and Arsenic
Toxic effects of heavy metals : Lead and ArsenicToxic effects of heavy metals : Lead and Arsenic
Toxic effects of heavy metals : Lead and Arsenic
sanjana502982
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
Richard Gill
 
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills MN
 
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless ReproducibilityDeep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless Reproducibility
University of Rennes, INSA Rennes, Inria/IRISA, CNRS
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
AlaminAfendy1
 
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Studia Poinsotiana
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
Lokesh Patil
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
ChetanK57
 
ISI 2024: Application Form (Extended), Exam Date (Out), Eligibility
ISI 2024: Application Form (Extended), Exam Date (Out), EligibilityISI 2024: Application Form (Extended), Exam Date (Out), Eligibility
ISI 2024: Application Form (Extended), Exam Date (Out), Eligibility
SciAstra
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Ana Luísa Pinho
 

Recently uploaded (20)

Leaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdfLeaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdf
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
 
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
 
bordetella pertussis.................................ppt
bordetella pertussis.................................pptbordetella pertussis.................................ppt
bordetella pertussis.................................ppt
 
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
 
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
 
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxThe use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
 
Toxic effects of heavy metals : Lead and Arsenic
Toxic effects of heavy metals : Lead and ArsenicToxic effects of heavy metals : Lead and Arsenic
Toxic effects of heavy metals : Lead and Arsenic
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
 
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
 
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless ReproducibilityDeep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless Reproducibility
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
 
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
 
ISI 2024: Application Form (Extended), Exam Date (Out), Eligibility
ISI 2024: Application Form (Extended), Exam Date (Out), EligibilityISI 2024: Application Form (Extended), Exam Date (Out), Eligibility
ISI 2024: Application Form (Extended), Exam Date (Out), Eligibility
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
 

HIPBI-RD: Harmonising phenomics information for a better interoperability in the rare disease field - Ana Rath

  • 1. www.orpha.net HIPBI-RD Harmonising phenomics information for a better interoperability in the RD field Ana Rath, Annie Olry, Marc Hanauer, Peter Robinson, Sebastian Köhler, Michael Brudno, Helen Parkinson, Simon Jupp,Tudor Groza ana.rath@inserm.fr Human Variome Project 6th Bienal meeting – UNESCO, Paris June 2016
  • 2. HIPBI-RD • Aims: – Contribute to harmonisation of phenotype annotations – Contribute to interoperability between patient-centered resources and genetic-centered resources We aim to provide the community with an integrated, RD-specific informatics ecosystem that will harmonize the way phenomics information is stored in databases and in patient files worldwide, and thereby contribute to interoperability. This ecosystem will consist of a suite of tools and ontologies, optimized to work together, and available to clinicians and scientists through commonly used software repositories. Additionally, the ecosystem will contribute to the interpretation of variants identified through exome and full genome sequencing by harmonizing the way phenotypic information is collected, thus improving diagnostics.
  • 3. Specific objectives • Integrate Human Phenotype Ontology (HPO) and Orphanet Rare Disease Ontology (ORDO). • Have ORDO & HPO translated in 7 languages. • Enrich rare disorder annotations via automated concept recognition (literature, records). • Enrich rare disorder annotations via Crowdsourcing. • Improve algorithms to allow clinical and genetic differential diagnosis. – Improve Phenomizer and Genomizer
  • 5. Orphanet Rare Diseases Onntology (ORDO) Orphanet & European Bioinformatics Institute (EBI)
  • 6. Helen Parkinson, Simon Jupp, EMBL-EBI, Hinxton, UK
  • 7. Peter Robinson, Sebastian Köhler, La Charité, Berlin, Germany
  • 8. HPO controlled vocabulary and the Phenomizer https://compbio.charite.de/phenomizer/
  • 9. HPO annotations of Orphanet Rare Disorders Around 6,000 rare disorders HPO phenotypes Frequencies Diagnostic criteria Obligate (100%) Pathognomonic sign Very frequent (99-80%) Diagnostic criterion Frequent (79-30%) Occasional (29–5%) Very rare (1-4%) Absent 0% Annotated by Orphanet Disseminated by Orphanet and HPO 2,340 rare disorders 5,750 phenotypes 49,600 annotations
  • 10. ORDO HPO Orphanet HPO Ontologies integrated Bio-named entity recognition Phenome Central Phenomizer Exomizer Hipbi-RD ecosystem Literature Re-use PhenoTips Crowdsourcing OKM Projet HIPBI-RD
  • 11. Bio-named recognition Bio-LarK CR Tudor Groza , Garvan Institute, Australia
  • 13. In conclusion… • Having structured data in databases (but also in the healthcare setting) is a cornerstone to foster research by allowing for agregation of interoperable data. • Providing an integrated, computable ontologies ecosystem will help to standardisation and harmonisation of phenotypic and clinical annotations. • The ecosystem will contribute to the interpretation of variants identified through exome and full genome sequencing by harmonizing the way phenotypic information is collected, thus improving diagnostics.
  • 14. THANK YOU FOR YOUR ATTENTION!

Editor's Notes

  1. Application submitted; 2 succesful rounds of evaluation. Building a bioinformatics ecosystem allowing for refining phenotype-diseases annotations and curation, improvement of ontological resources via semantic interpretation of literature and crowdsourcing. Integration to genes in ORDO allowing for genotype-phenotype correlations. Re-use in the Exomizer, the Phenomizer and available for re-use in databases, matchmakers, etc The Hipbi-RD ecosystem will consist of a suite of tools and ontologies, optimized to work together, and available to clinicians and scientists through commonly used software repositories, such as GitHub. It builds on our two existing ontologies: ORDO and HPO, which are promoted as reference ontologies in the field of RD by the IRDiRC (International Rare Diseases Research Consortium), the broadly used PhenoTips tool used for collecting structured patient data and the PhenomeCentral matchmaker portal, and expands tools developed by Bio-Lark and the European Bioinformatics Institute (EBI). This proposal therefore aims to provide the community with an integrated, RD-specific informatics ecosystem that will harmonize the way phenomics information is stored in databases and in patient files worldwide, and thereby contributing to interoperability between databases, registries and biobanks.
  2. Application submitted; 2 succesful rounds of evaluation. Building a bioinformatics ecosystem allowing for refining phenotype-diseases annotations and curation, improvement of ontological resources via semantic interpretation of literature and crowdsourcing. Integration to genes in ORDO allowing for genotype-phenotype correlations. Re-use in the Exomizer, the Phenomizer and available for re-use in databases, matchmakers, etc